16.11
price down icon4.16%   -0.685
 
loading

Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
17.21%
12.09
10.31 10.66 7.703 7.23
Costs And Expenses
12.36%
20.27
18.04 20.26 13.65 11.73
Operating Income/Loss
12.36%
-20.27
-18.04 -20.26 -13.65 -11.73
Nonoperating Income/Loss
11.37%
1.107
1.249 0.876 0.975 0.343
Income/Loss From Continuing Operations Before Tax
14.13%
-19.17
-16.80 -19.39 -12.68 -11.38
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
14.13%
-19.17
-16.80 -19.39 -12.68 -11.38
Net Income/Loss
14.13%
-19.17
-16.80 -19.39 -12.68 -11.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.22%
67.28
67.13 1.229 61.07 57.18
Basic Earnings Per Share
12.00%
-0.28
-0.25 -0.32 -0.21 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
medical_instruments_supplies BAX
$18.00
price down icon 1.18%
$135.31
price down icon 2.22%
$68.67
price up icon 0.82%
medical_instruments_supplies COO
$69.53
price down icon 0.37%
$74.22
price up icon 0.20%
medical_instruments_supplies WST
$286.14
price up icon 2.28%
Kapitalisierung:     |  Volumen (24h):